Best Practices Forum: Icosapent ethyl for whom and when? A case-based discussion
Details & Video
This program offers participants downloadable slides and a program worksheet. View the PROGRAM MATERIALS tab for more information.
The program was developed by the Canadian Collaborative Research Network and was presented as a live virtual event on October 1, 2020. We are pleased to make the recordings of the live session available to you through MD-Online. Please select the session below to participate. The PROGRAM SLIDES are available from the CCRN booth in the virtual exhibit hall link below.
Thank you to our sponsor who supported this program through an unrestricted educational grant.
Overview & Objectives
This program is intended for primary care physicians, cardiologists, endocrinologists and lipidologists.
Through an interactive case-based discussion, this program will help practitioners identify the appropriate patient and timing for icosapent ethyl therapy to achieve additional cardiovascular risk reduction.
This program is NOT accredited.
Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.
Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio.
|Case 1: A patient with stable ASCVD and optimized LDL||Milan Gupta|
|Case 2: A patient with diabetes and additional risk factors||Alice Cheng|
|Case 3: A patient with ASCVD and elevated LDL and TG||Milan Gupta|
|Case 4: A patient with ASCVD with concomitant atrial fibrillation||Peter Lin|
|Case 1: A patient with stable ASCVD and optimized LDL|
|Case 2: A patient with diabetes and additional risk factors|
|Case 3: A patient with ASCVD and elevated LDL and TG|
|Case 4: A patient with ASCVD with concomitant atrial fibrillation|
This program has been developed by the Canadian Collaborative Research Network, a not-for-profit physician organization, and is supported through an educational grant received from: